citE Family assigned · medium auto-curated

H37Rv Rv2498c · MTBC0 mtbc0_002660 · 273 aa · 2835245–2836066 MTBC0 (-) · RefSeq NP_217014.1

Genomic neighbourhood (genome browser)

Open in full genome browser →
+ strand − strand Rv2489c (Rv2489c) — dark: hypothetical protein Rv2491 (Rv2491) — family_assigned: TIGR00725 family protein Rv2492 (Rv2492) — requalified: hypothetical protein vapB38 (Rv2493) — requalified: antitoxin vapC38 (Rv2494) — family_assigned: type II toxin-antitoxin system VapC family toxin bkdC (Rv2495c) — family_assigned: dihydrolipoamide acetyltransferase family protein bkdC bkdB (Rv2496c) — family_assigned: 3-methyl-2-oxobutanoate dehydrogenase subunit beta bkdB bkdA (Rv2497c) — family_assigned: pyruvate dehydrogenase (acetyl-transferring) E1 component su bkdA citE (Rv2498c) — family_assigned: citrate (pro-3S)-lyase subunit beta Rv2499c (Rv2499c) — family_assigned: MaoC family dehydratase fadE19 (Rv2500c) — family_assigned: acyl-CoA dehydrogenase family protein fadE19 accA1 (Rv2501c) — family_assigned: acetyl/propionyl/methylcrotonyl-CoA carboxylase subunit alph accA1 accD1 (Rv2502c) — family_assigned: acetyl-/propionyl-CoA carboxylase subunit beta accD1 scoB (Rv2503c) — family_assigned: succinyl-CoA--3-ketoacid CoA transferase subunit B scoA (Rv2504c) — family_assigned: succinyl-CoA--3-ketoacid CoA transferase subunit A fadD35 (Rv2505c) — family_assigned: AMP-binding protein fadD35 Rv2506 (Rv2506) — family_assigned: TetR/AcrR family transcriptional regulator Rv2507 (Rv2507) — family_assigned: MmpS family transport accessory protein Rv2508c (Rv2508c) — requalified: MFS transporter Rv2508c cmrA (Rv2509) — requalified: mycolate reductase 2 824 kb 2 828 kb 2 832 kb 2 836 kb 2 840 kb 2 844 kb

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)citrate (pro-3S)-lyase subunit beta
MTBC0 PGAP re-annotationcitrate (pro-3S)-lyase subunit beta
Revised (this work)Citrate (pro-3S)-lyase subunit beta. Pfam: HpcH_HpaI (PF03328.21), C-C_Bond_Lyase (PF15617.13).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 79 publications

79 TB publications mention this gene. 79 publications discuss this gene. Queried separately, 72 records carry a M. tuberculosis context and 2 a non-TB mycobacterial context (species named in the 2-record verified sample: M. leprae (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 79: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Single-Cell Immune Atlases to Map Small Extracellular Vesicle Cargo in Tuberculosis-Diabetes Comorbidity: A Narrative Review and Conceptual Roadmap. doi:10.3390/ijms27083437 2026
The Sustainable Goal of Eliminating Hepatitis B, Functional Cure, and the Prospect of NASVAC: A Review. doi:10.5005/jp-journals-10018-1483 2025
CD4+ mucosal-associated invariant T cells express highly diverse T cell receptors. doi:10.1093/jimmun/vkaf260 2025
Persistent Increased Plasmacytoid Dendritic Cells and Inflammation in People With HIV Years After Tuberculosis. doi:10.1093/infdis/jiaf499 2026
Bibliometric insights into transforming the management of rheumatoid arthritis: three decades of progress against opportunistic infections. doi:10.55563/clinexprheumatol/7q3n0m 2025
615 records returned by the alias sweep

Searched as: Rv2498c, citE, Mb2526c, MMAR_3845, MSMEG_4713, MAB_4378c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

This count disagrees with the 79 reported above. The two come from different methods and both are shown rather than one being silently overwritten. The figure above comes from the older curated source, which missed this gene; the sweep below queries every alias of the gene in a mycobacterial context. Where they differ this way, the list below is the one you can check line by line.

PublicationJournalYear
Mycobacterial infections and recurrent osteomyelitis in a patient with an autosomal dominant mutation in IFN-gamma receptor 1 with overexpression of the receptor. doi:10.1016/j.ijid.2026.109104 Int J Infect Dis 2026
Human-inherited RORγT deficiency encompasses genetic heterogeneity, T cell deficiency, and clinical homogeneity. doi:10.1084/jem.20252038 J Exp Med 2026
First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial. doi:10.1016/j.lungcan.2026.109589 Lung Cancer 2026
Persistent Ascites Revealing Mendelian Susceptibility to Mycobacterial Disease Due to IL-12Rβ1 Deficiency: A Case Report and Review of the Literature. doi:10.1155/crii/3587297 Case Reports Immunol 2026
STAT1 gain-of-function in 12 Moroccan patients: Clinical and genetic insights. doi:10.70962/jhi.20250021 J Hum Immun 2026
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases. doi:10.1002/clt2.70192 Clin Transl Allergy 2026
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S2468-2667(26)00145-3 Lancet Public Health 2026
Efficacy and safety of oral treatments for allergic rhinitis in children: A network meta-analysis. doi:10.1111/pai.70431 Pediatr Allergy Immunol 2026
The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium tuberculosis. doi:10.1002/advs.76832 Adv Sci (Weinh) 2026
MRI Characteristics Distinguishing Tuberculous Arthritis from Rheumatoid Arthritis: A Comparative Study. doi:10.5152/eurjrheum.2026.25058 Eur J Rheumatol 2026
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed Strategies. doi:10.1002/med.70096 Med Res Rev 2026
Human inherited RORγT deficiency encompasses genetic heterogeneity, T cell deficiency, and clinical homogeneity. doi:10.64898/2026.07.18.26358075 medRxiv 2026
Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens. doi:10.1183/13993003.00989-2026 Eur Respir J 2026
Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. doi:10.1001/jama.2026.8628 JAMA 2026
Beyond Cure: A Scoping Review of Post-Tuberculosis Long-Term Health Outcomes. doi:10.3390/tropicalmed11070203 Trop Med Infect Dis 2026
Global, regional, and national burden of road injuries 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S2468-2667(26)00141-6 Lancet Public Health 2026
The Relationship Between Feelings of Stigma in Tuberculosis Patients and the Social Support Provided by Household Contacts: A Cross-Sectional Study. doi:10.5152/FNJN.2026.25033 Florence Nightingale J Nurs 2026
The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis. doi:10.1183/23120541.01397-2025 ERJ Open Res 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis. doi:10.1084/jem.20252236 J Exp Med 2026
Assessing Corynebacterium glutamicum as a surrogate of Mycobacterium tuberculosis for DNA gyrase inhibitor design. doi:10.64898/2026.06.24.734172 bioRxiv 2026
Evidence and Consensus-Based Imaging Guidelines in Tubercular Choroiditis: Multimodal Imaging in Uveitis (MUV) Task Force: Report 17. doi:10.1016/j.oret.2026.06.023 Ophthalmol Retina 2026
Human Macrophages Secrete Both Interferon α and Interferon β Proteins During Infection with Mycobacterium tuberculosis. doi:10.1177/10799907261446997 J Interferon Cytokine Res 2026
The frequent exacerbator phenotype in bronchiectasis revisited: data from EMBARC registry. doi:10.1093/ajrccm/aamag297 Am J Respir Crit Care Med 2026
Drug interaction between maribavir and rifampin: a case report. doi:10.1016/j.ijid.2026.108904 Int J Infect Dis 2026
Disease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis-infected macaques. doi:10.1093/jimmun/vkag114 J Immunol 2026
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists. doi:10.20411/pai.v11i1.970 Pathog Immun 2026
Genetically diverse CC and DO mouse models enable comprehensive assessments of novel tuberculosis vaccines. doi:10.1038/s41541-026-01498-6 NPJ Vaccines 2026
TBSure: an ESGMYC survey of pediatric TB management practices in high-income countries. doi:10.3389/fpubh.2026.1829612 Front Public Health 2026
Activation mechanism and structural assembly of the Mycobacterium tuberculosis ClpP1P2 protease and its associated ATPases. doi:10.1016/j.celrep.2026.117400 Cell Rep 2026
Practices in reporting incidental findings in lung cancer screening by low-dose CT: a European Survey of Radiologists by SOLACE. doi:10.1186/s13244-026-02257-w Insights Imaging 2026
Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective (part 2: special situations/respiratory complications). doi:10.1016/j.rmed.2026.108911 Respir Med 2026
Chronic granulomatous disease: Clinical, microbial, and genetic findings in 39 Colombian patients. doi:10.70962/jhi.20250257 J Hum Immun 2026
Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis. doi:10.1016/j.vaccine.2026.128753 Vaccine 2026
Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India. doi:10.70962/jhi.20250153 J Hum Immun 2026
Revisiting gonorrhoea prevention in the era of resistance and biomedical interventions. doi:10.1136/sextrans-2025-056896 Sex Transm Infect 2026
Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(26)00519-2 Lancet 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries. doi:10.1016/S2213-2600(26)00057-3 Lancet Respir Med 2026
The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee. doi:10.1016/j.cmi.2026.05.012 Clin Microbiol Infect 2026
Infectious contamination of healthcare workers. doi:10.1016/j.lpm.2026.104349 Presse Med 2026
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries. doi:10.1371/journal.pgph.0006293 PLOS Glob Public Health 2026
Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study. doi:10.1111/cea.70335 Clin Exp Allergy 2026
Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations. doi:10.1093/ajrccm/aamag152 Am J Respir Crit Care Med 2026
Single-Cell Immune Atlases to Map Small Extracellular Vesicle Cargo in Tuberculosis-Diabetes Comorbidity: A Narrative Review and Conceptual Roadmap. doi:10.3390/ijms27083437 Int J Mol Sci 2026
A disrupted microbial network and an ecological shift towards anaerobes in NTM-infected cystic fibrosis patients. doi:10.1016/j.jcf.2026.04.005 J Cyst Fibros 2026
Series 3: From Infection to Disease: A Global Scoping Review of Medical and Behavioural Determinants of Progression from TB Infection to TB Disease. doi:10.3390/tropicalmed11040094 Trop Med Infect Dis 2026
Series 2: Invisible Threats: A Global Scoping Review of Risk Factors for Tuberculosis Infection. doi:10.3390/tropicalmed11040087 Trop Med Infect Dis 2026
Air conditioning, ventilation, and respiratory virus transmission potential in South India. doi:10.1016/j.ijid.2026.108724 Int J Infect Dis 2026
Smooth-to-rough morphotype alterations in Mycobacterium abscessus and their putative impact on phage resistance. doi:10.1073/pnas.2606859123 Proc Natl Acad Sci U S A 2026
Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts. doi:10.1111/all.70340 Allergy 2026
The orphan receptor GPR84 drives inflammation in Buruli ulcer development. doi:10.1126/scitranslmed.ads8681 Sci Transl Med 2026
An ESAT-6-convergent prime-boost vaccination combining recombinant BCG expressing Mycobacterium marinum ESX-1 and ESAT-6/GLA-SE improves TB protection. doi:10.1038/s41541-026-01439-3 NPJ Vaccines 2026
Intrinsic differences in hamster and mouse macrophage biology correlate with susceptibility to Leishmania donovani infection. doi:10.1093/jleuko/qiag027 J Leukoc Biol 2026
Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis. doi:10.1093/infdis/jiag194 J Infect Dis 2026
Structural basis of Mycobacterium Fluoroquinolone Resistance Protein D (MfpD), a versatile pathogeny protein from the mfp conservon of Mycobacterium tuberculosis. doi:10.64898/2026.03.03.709265 bioRxiv 2026
Genome-wide detection of human 5' UTR variants that impact protein translation. doi:10.1016/j.ajhg.2026.02.020 Am J Hum Genet 2026
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments. doi:10.1111/all.70305 Allergy 2026
Human genetic ancestry, Mycobacterium tuberculosis diversity, and tuberculosis disease severity in Dar es Salaam, Tanzania. doi:10.7554/eLife.103533 Elife 2026
Determinants of early Elexacaftor-Tezacaftor-Ivacaftor use in adults with cystic fibrosis and preserved lung function: insights from a European multicenter survey. doi:10.1016/j.jcf.2026.03.005 J Cyst Fibros 2026
Local agricultural transition, crisis and migration in the Southern Andes. doi:10.1038/s41586-026-10233-z Nature 2026
Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021. doi:10.3904/kjim.2025.278 Korean J Intern Med 2026
Multiple cold abscesses of the penis due to Mycobacterium bovis following BCG therapy. doi:10.1016/j.annder.2026.103476 Ann Dermatol Venereol 2026
Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis. doi:10.1016/S2468-1253(25)00302-4 Lancet Gastroenterol Hepatol 2026
Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysis. doi:10.1016/S2468-1253(25)00301-2 Lancet Gastroenterol Hepatol 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study. doi:10.1093/cid/ciag171 Clin Infect Dis 2026
Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency. doi:10.1097/HEP.0000000000001710 Hepatology 2026
Tuberculosis after allogeneic hematopoietic stem cell transplantation: a decade nationwide case-control retrospective study in low-incidence country. doi:10.1038/s41409-026-02800-9 Bone Marrow Transplant 2026
Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1470-2045(25)00730-2 Lancet Oncol 2026
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial. doi:10.1016/S2352-3018(26)00033-0 Lancet HIV 2026
Series 1: Behind the Spread: A Scoping Review of Risk Factors for Exposure to Mycobacterium tuberculosis. doi:10.3390/tropicalmed11020058 Trop Med Infect Dis 2026
Response-adaptive randomization with imperfect intermediate endpoints. doi:10.1177/17407745261415792 Clin Trials 2026
Improved immune responses and tuberculosis protection by aerosol vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum. doi:10.1371/journal.ppat.1013992 PLoS Pathog 2026
Membrane-associated effluxosomes coordinate multi-metal resistance in Mycobacterium tuberculosis. doi:10.1038/s44318-026-00715-1 EMBO J 2026
Complete and partial forms of X-linked MCTS1 deficiency in patients with mycobacterial disease. doi:10.70962/jhi.20250073 J Hum Immun 2026
From Plato to Pareto: Defining the shape of infection's disease space. doi:10.1126/sciadv.aeb3911 Sci Adv 2026
Mechanistic insights into SteAB regulation of cell wall hydrolase RipA in Mycobacterium tuberculosis. doi:10.1128/mbio.03700-25 mBio 2026
From barriers to solutions: a qualitative study of access to HIV and TB care for forced migrants from Ukraine. doi:10.1186/s12913-025-13946-5 BMC Health Serv Res 2026
Immune activation and response dynamics of human iPSC-derived macrophages in tuberculosis infection models. doi:10.1002/cti2.70071 Clin Transl Immunology 2026
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial. doi:10.1016/j.resinv.2025.101357 Respir Investig 2026
Migrations and Tuberculosis: A comparative study of Mycobacterium tuberculosis genomic population structure in Brazil and Mozambique to historical triangular slave trade knowledge to reconstruct the origins of tuberculosis infections caused by Lineage 1 in Brazil. doi:10.1016/j.tube.2026.102734 Tuberculosis (Edinb) 2026
Reply: From the authors of the ERS/ATS statement on the international multidisciplinary classification of the interstitial pneumonias. doi:10.1183/13993003.02271-2025 Eur Respir J 2026
Accuracy of VIDAS(Ⓡ) TB-IGRA in TB patients and individuals with different thresholds of exposure. doi:10.1016/j.ijid.2025.108318 Int J Infect Dis 2026
Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis. doi:10.1183/13993003.01046-2025 Eur Respir J 2026
Impact of delayed incubation on mycobacterial blood culture recovery with the BACTEC Myco/F Lytic system. doi:10.1016/j.diagmicrobio.2025.117217 Diagn Microbiol Infect Dis 2026
TNF Inhibitor-Induced Sarcoidosis-Like Lesions in Inflammatory Bowel Disease. doi:10.1002/ueg2.70015 United European Gastroenterol J 2026
Optimizing the Use of Inhaled Corticosteroid/Long-Acting β(2)-Agonist Combinations in Patients with Moderate-to-Severe Asthma. doi:10.1007/s12325-025-03406-1 Adv Ther 2026
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments. doi:10.1111/all.70131 Allergy 2026
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms. doi:10.1111/all.70100 Allergy 2026
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data. doi:10.1111/cea.70173 Clin Exp Allergy 2026
Global, regional, and national burden of Chagas disease, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(25)00562-6 Lancet Infect Dis 2026
Persistent Increased Plasmacytoid Dendritic Cells and Inflammation in People With HIV Years After Tuberculosis. doi:10.1093/infdis/jiaf499 J Infect Dis 2026
International Thymic Malignancy Interest Group Standard Definitions, Policies, and Reporting Measures for Thymic Epithelial Tumors. doi:10.1016/j.jtho.2025.09.1757 J Thorac Oncol 2026
Vaccine adjuvants as stand-alone immunoprophylaxis in strategies for 100-day rapid responses to future pandemics. doi:10.1093/intimm/dxaf053 Int Immunol 2026
Physiological Consequences of Breathing Effort According to the Mode of Ventilation during Acute Hypoxemic Respiratory Failure. doi:10.1164/rccm.202411-2155OC Am J Respir Crit Care Med 2026
Laboratory-associated infections and biosafety. doi:10.1016/j.lpm.2025.104277 Presse Med 2026
Evaluation of Transmissible Diseases and Preventive Measures Awareness Level among Dental Auxiliaries in Dental Schools of Kerala: A Cross-sectional Study. doi:10.5005/jp-journals-10024-3976 J Contemp Dent Pract 2025
A patient with complete IFN-γR1 deficiency and tuberculosis resembling BCG disease. doi:10.70962/jhi.20250013 J Hum Immun 2025
The Sustainable Goal of Eliminating Hepatitis B, Functional Cure, and the Prospect of NASVAC: A Review. doi:10.5005/jp-journals-10018-1483 Euroasian J Hepatogastroenterol 2025
Impact of indoor ventilation on TB transmission risk: implications of climate change. doi:10.5588/ijtld.25.0129 Int J Tuberc Lung Dis 2025
Serological diagnosis of chronic skin granulomas caused by wild-type or vaccine-derived rubella virus in patients with inherited HLA class I deficiency. doi:10.70962/jhi.20250103 J Hum Immun 2025
Clinical standards for antimicrobial stewardship in TB care. doi:10.5588/ijtldopen.25.0522 IJTLD Open 2025
Reply: The rationale for distinguishing RB-ILD and AMP. doi:10.1183/13993003.02029-2025 Eur Respir J 2025
Reply: Bronchiolocentric interstitial pneumonia is a morphological term used for lung biopsy and chest imaging pattern and is not a substitute for hypersensitivity pneumonitis. doi:10.1183/13993003.02009-2025 Eur Respir J 2025
Tolerance of Plasmodium falciparum mefloquine-resistant clinical isolates to mefloquine-piperaquine with implications for triple artemisinin-based combination therapies. doi:10.1038/s41467-025-65629-8 Nat Commun 2025
Clinical evaluation of the diagnostic performances and treatment monitoring of the new PATHFAST TB LAM Ag assay in sputum specimens of patients with tuberculosis or with nontuberculous mycobacteria pulmonary disease. doi:10.1128/jcm.01269-25 J Clin Microbiol 2025
Contribution of maternal gut carriage to neonatal acquisition of extended-spectrum beta-lactamase-producing Enterobacterales in Madagascar and Cambodia. doi:10.1038/s41467-025-65352-4 Nat Commun 2025
Measuring Dedicator of Cytokinesis 8 (DOCK8) Expression as a Flow Cytometry Biomarker for DOCK8 Deficiency Detection. doi:10.18502/ijaai.v24i6.20158 Iran J Allergy Asthma Immunol 2025
CD4+ mucosal-associated invariant T cells express highly diverse T cell receptors. doi:10.1093/jimmun/vkaf260 J Immunol 2025
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications. doi:10.1186/s12890-025-03976-4 BMC Pulm Med 2025
Exploring individual and structural factors influencing healthcare seeking behavior in the context of the Senegal's Universal Health Coverage program: a multilevel analysis from the ANRS-12399 Soignants Sénégal study. doi:10.1186/s12913-025-13611-x BMC Health Serv Res 2025
When Emerging Fungal Infections Mimic Tuberculosis: First Reported Case of Invasive Emergomyces europaeus Infection in a Man With Immunocompromise Living in France. doi:10.1093/ofid/ofaf621 Open Forum Infect Dis 2025
Genomic characterization and epidemiology of Mycobacterium tuberculosis lineage 2 isolates from Kazakhstan. doi:10.1038/s41598-025-22485-2 Sci Rep 2025
A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure. doi:10.1186/s13073-025-01547-0 Genome Med 2025
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01917-8 Lancet 2025
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01330-3 Lancet 2025
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01637-X Lancet 2025
Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis. doi:10.1016/S1473-3099(25)00157-4 Lancet Infect Dis 2025
Thrombocytopenia in patients with inborn errors of immunity. doi:10.1186/s12865-025-00761-0 BMC Immunol 2025
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01635-6 Lancet 2025
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A MASK-air and EAACI Methodological Committee Report. doi:10.1111/all.70055 Allergy 2025
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. doi:10.1016/j.jacc.2025.08.015 J Am Coll Cardiol 2025
Inorganic sulfate is critical for Mycobacterium tuberculosis lung tissue colonization and redox balance. doi:10.1073/pnas.2503966122 Proc Natl Acad Sci U S A 2025
Area-level socioeconomic variables associated with territorial disparities in tuberculosis notification rates in metropolitan France: a Bayesian ecological analysis. doi:10.1186/s40249-025-01354-0 Infect Dis Poverty 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study. doi:10.1016/S2213-2600(25)00160-2 Lancet Respir Med 2025
Artificial intelligence for TB education and counselling: a modified Delphi consensus. doi:10.5588/ijtld.25.0086 Int J Tuberc Lung Dis 2025
Clinical, biochemical, and molecular findings in adults with hyperammonemia: A French bi-centric retrospective study. doi:10.1016/j.ymgme.2025.109223 Mol Genet Metab 2025
Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement. doi:10.1183/13993003.00158-2025 Eur Respir J 2025
Standardized Clinical Terms and Definitions for Interstitial Lung Disease: A Consensus Statement from the Fleischner Society. doi:10.1164/rccm.202505-1142SO Am J Respir Crit Care Med 2025
Bibliometric insights into transforming the management of rheumatoid arthritis: three decades of progress against opportunistic infections. doi:10.55563/clinexprheumatol/7q3n0m Clin Exp Rheumatol 2025
Infectious Disease Emergencies in Older Adults in India: A Prospective Observational Study Comparing Youngest Old, Middle Old, and Oldest Old Patients. doi:10.5005/jp-journals-10071-25000 Indian J Crit Care Med 2025
Multifactorial drivers of engagement in sex work among Ethiopian women: a multinomial logistic regression approach. doi:10.3389/fgwh.2025.1512560 Front Glob Womens Health 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthma. doi:10.1080/25310429.2025.2532980 Pulmonology 2025
Summary of taxonomy changes ratified by the International Committee on Taxonomy of Viruses (ICTV) from the Bacterial Viruses Subcommittee, 2025. doi:10.1099/jgv.0.002111 J Gen Virol 2025
Artificial intelligence for tuberculosis control: a scoping review of applications in public health. doi:10.7189/jogh.15.04192 J Glob Health 2025
Noninvasive respiratory supports in ICU. doi:10.1007/s00134-025-08036-3 Intensive Care Med 2025
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study. doi:10.1016/j.lanepe.2025.101380 Lancet Reg Health Eur 2025
The addition of amoxicillin improves the efficacy of the imipenem-avibactam combination against Mycobacterium abscessus in a mouse model of infection. doi:10.1128/aac.00534-25 Antimicrob Agents Chemother 2025
An insight into the characterization of L2 Beijing multi-drug resistant tuberculosis: Description of resistance-associated-variants and discovery of Modern 7 L2 sublineage. doi:10.1016/j.meegid.2025.105797 Infect Genet Evol 2025
Neuroimaging for prognosis of central nervous system infections: a systematic review and meta-analysis. doi:10.1186/s13613-025-01516-1 Ann Intensive Care 2025
Standardised protocol for the detection and quantification of nontuberculous mycobacteria (NTM) in tap water and its application in investigating the source of NTM clinical infections. doi:10.1016/j.ijheh.2025.114618 Int J Hyg Environ Health 2025
A set of plasmatic microRNA related to innate immune response highly predicts the onset of immune reconstitution inflammatory syndrome in tuberculosis co-infected HIV individuals (ANRS-12358 study). doi:10.3389/fimmu.2025.1603338 Front Immunol 2025
Pilot Implementation of HIV Self-Testing Delivery in Private Pharmacies Combined With a Respondent-Driven Sampling Method to Improve HIV Testing for Men Who Have Sex With Men and Transgender Women in Phnom Penh (ANRS 0100s): Protocol for a Prospective Mixed Method Feasibility Study. doi:10.2196/65351 JMIR Res Protoc 2025
Clinical best practices for caring for people with expanded resistance to newer TB drugs. doi:10.5588/ijtldopen.25.0240 IJTLD Open 2025
Virtual Screening of Novel Benzothiozinone Derivatives to Predict Potential Inhibitors of Mycobacterium Tuberculosis Kinases 2D-QSAR, Molecular Docking, MM-PBSA Dynamics Simulations, and ADMET Properties. doi:10.3390/ijms26115129 Int J Mol Sci 2025
Naproxen and prednisolone reduced intestinal alteration and permeability and bacterial translocation in rat adjuvant-induced arthritis. doi:10.1007/s10787-025-01791-1 Inflammopharmacology 2025
Human LY9 governs CD4(+) T cell IFN-γ immunity to Mycobacterium tuberculosis. doi:10.1126/sciimmunol.ads7377 Sci Immunol 2025
Differentiation of nodular pulmonary infections in immunocompromised patients using CT-based radiomics. doi:10.1016/j.diii.2025.05.004 Diagn Interv Imaging 2025
Pre-European contact leprosy in the Americas and its current persistence. doi:10.1126/science.adu7144 Science 2025
Post-tuberculosis lung disease patients benefit from vaccinations as other respiratory conditions. doi:10.4081/monaldi.2025.3525 Monaldi Arch Chest Dis 2025
Comparison of a modified broth microdilution Sensititre™ SLOMYCOI assay with the CLSI-recommended agar disk elution method for antimicrobial susceptibility testing of Mycobacterium haemophilum. doi:10.1093/jac/dkaf162 J Antimicrob Chemother 2025
Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148. doi:10.1128/spectrum.03224-24 Microbiol Spectr 2025
Genome Mining and Chemistry-Driven Discovery of a Cell Wall Lipopeptide Signature for Mycobacterium avium subsp. paratuberculosis Ancestral Lineage. doi:10.1021/acsinfecdis.5c00181 ACS Infect Dis 2025
Histoplasma Antigenuria Prevalence in Patients With Advanced HIV Disease in Côte d'Ivoire: A Prospective Trial Ancillary Study. doi:10.1093/cid/ciaf237 Clin Infect Dis 2025
Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis. doi:10.1128/jcm.01641-24 J Clin Microbiol 2025
Unprecedented in vivo activity of telacebec against Mycobacterium leprae. doi:10.1371/journal.pntd.0013076 PLoS Negl Trop Dis 2025
Granulomatous lymphadenopathy and tuberculosis: accuracy of histology. doi:10.1016/j.ijid.2025.107920 Int J Infect Dis 2025
CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potential. doi:10.1038/s41598-025-98367-4 Sci Rep 2025
Impact of US Government funding cessation on TB care and prevention: a multicountry survey in Africa. doi:10.5588/ijtld.24.0215 Int J Tuberc Lung Dis 2025
Leveraging Artificial Intelligence to Predict Potential TB Hotspots at the Community Level in Bangui, Republic of Central Africa. doi:10.3390/tropicalmed10040093 Trop Med Infect Dis 2025
ENaC is a host susceptibility factor to bacterial infections in cystic fibrosis context. doi:10.1038/s42003-025-07877-4 Commun Biol 2025
Human IL-6-Producing B Cells Promote the Differentiation of Monocytes Toward an Anti-Inflammatory CD16⁺CD163⁺CD206⁺PD-L1⁺ Phenotype in Tuberculosis. doi:10.1002/eji.202451509 Eur J Immunol 2025
Usefulness of the GeneXpert MTB/RIF Ct for predicting tuberculosis infectiousness. doi:10.1016/j.idnow.2025.105061 Infect Dis Now 2025
In vitro, intracellular and in vivo synergy between amoxicillin, imipenem and relebactam against Mycobacterium abscessus. doi:10.1093/jac/dkaf101 J Antimicrob Chemother 2025
Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis: Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109. doi:10.1021/acsinfecdis.4c00893 ACS Infect Dis 2025
ERS Clinical Research Collaboration programme: more than research networking - enriching respiratory science and impacting clinical practice in Europe and beyond. doi:10.1183/13993003.02520-2024 Eur Respir J 2025
A prenatal testing program among future fathers in a Paris metropolitan area maternity reveals a high proportion of undiagnosed and not linked to care chronic viral hepatitis B. doi:10.1016/j.cmi.2025.03.015 Clin Microbiol Infect 2025
A roadmap for integrating nutritional assessment, counselling, and support into the care of people with tuberculosis. doi:10.1016/S2214-109X(25)00021-X Lancet Glob Health 2025
Hepatitis B core-related antigen rapid diagnostic test for point-of-care identification of women at high risk of hepatitis B vertical transmission: a multicountry diagnostic accuracy study. doi:10.1016/S2468-1253(25)00015-9 Lancet Gastroenterol Hepatol 2025
Seroprevalence of Diphtheria in Antananarivo, Madagascar, and Cambodia. doi:10.1093/ofid/ofaf091 Open Forum Infect Dis 2025
Pulmonary Rehabilitation in Patients With Post-Tuberculosis Lung Disease: A Prospective Multicentre Study. doi:10.1016/j.arbres.2025.02.007 Arch Bronconeumol 2025
Long-term outcomes of patients with central nervous system tuberculosis in a high-income country: a retrospective study. doi:10.1016/j.cmi.2025.02.028 Clin Microbiol Infect 2025
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkers. doi:10.1016/j.ebiom.2025.105611 EBioMedicine 2025
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK-air Study. doi:10.1111/cea.70004 Clin Exp Allergy 2025
Impact of Nutritional Support for Tuberculosis on Intermediate and Terminal Undernutrition and Treatment Outcomes (INSTITUT) study: a protocol for a quasi-experimental study to assess the impact of nutritional support on tuberculosis treatment outcomes in Benin and Togo. doi:10.1136/bmjopen-2024-088629 BMJ Open 2025
Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered. doi:10.1097/QAD.0000000000004142 AIDS 2025
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation study. doi:10.1016/S2214-109X(24)00472-8 Lancet Glob Health 2025
Chest Radiograph in Migrant Children. doi:10.1097/INF.0000000000004756 Pediatr Infect Dis J 2025
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users. doi:10.18176/jiaci.1047 J Investig Allergol Clin Immunol 2025
Itaconate mechanism of action and dissimilation in Mycobacterium tuberculosis. doi:10.1073/pnas.2423114122 Proc Natl Acad Sci U S A 2025
Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli. doi:10.1172/JCI188016 J Clin Invest 2025
FhaA plays a key role in mycobacterial polar elongation and asymmetric growth. doi:10.1128/mbio.02526-24 mBio 2025
Mycobacterium chelonae cutaneous infections unrelated to invasive procedures: A multicentre retrospective case series. doi:10.1111/jdv.20521 J Eur Acad Dermatol Venereol 2025
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals. doi:10.1007/s12325-024-03043-0 Adv Ther 2025
Accuracy of Xpert and alternative sampling methods to diagnose childhood pulmonary tuberculosis, a prospective cohort study. doi:10.1016/j.cmi.2024.11.002 Clin Microbiol Infect 2025
Comparison of Tuberculosis Cases in Military Personnel Versus Civilians: A Retrospective Descriptive Study. doi:10.1093/milmed/usae503 Mil Med 2025
Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry. doi:10.1016/j.chest.2024.06.3843 Chest 2025
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype). doi:10.1053/j.gastro.2024.10.010 Gastroenterology 2025
Risk factors for non-isolation of patients admitted for pulmonary tuberculosis in a high-incidence department: a single-centre retrospective study. doi:10.1016/j.jhin.2024.09.020 J Hosp Infect 2025
A new quantitative reverse transcription PCR assay to improve the routine diagnosis of paracoccidioidomycosis. doi:10.1093/mmy/myae125 Med Mycol 2024
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. doi:10.1056/NEJMoa2405485 N Engl J Med 2024
The Trend of Tuberculosis Case Notification Rates from 1995 to 2022 by Country Income and World Health Organization Region. doi:10.3390/tropicalmed9120294 Trop Med Infect Dis 2024
Nutritionally acquired immunodeficiency must be addressed with the same urgency as HIV to end tuberculosis. doi:10.1186/s44263-023-00035-0 BMC Glob Public Health 2024
Prioritisation of infectious diseases from a public health perspective: a multi-criteria decision analysis study, France, 2024. doi:10.2807/1560-7917.ES.2024.29.50.2400074 Euro Surveill 2024
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies. doi:10.1017/S0266462324000552 Int J Technol Assess Health Care 2024
Pathogenic role of acyl coenzyme A binding protein (ACBP) in Cushing's syndrome. doi:10.1038/s42255-024-01170-0 Nat Metab 2024
Endocarditis associated with contamination of cardiovascular bioprostheses with Mycobacterium chelonae: a collaborative microbiological study. doi:10.1016/j.lanmic.2024.06.001 Lancet Microbe 2024
Building social equity and person-centred innovation into the end TB response. doi:10.5588/ijtld.24.0338 Int J Tuberc Lung Dis 2024
Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortium. doi:10.1186/s13244-024-01814-5 Insights Imaging 2024
Molecular mechanism of a triazole-containing inhibitor of Mycobacterium tuberculosis DNA gyrase. doi:10.1016/j.isci.2024.110967 iScience 2024
Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis. doi:10.1093/cid/ciae497 Clin Infect Dis 2024
Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study. doi:10.1186/s13054-024-05110-y Crit Care 2024
Detection and characterization of HIV-1 group O and HIV-2 in the Central African Republic. doi:10.1111/apm.13474 APMIS 2024
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021. doi:10.1016/S2468-2667(24)00166-X Lancet Public Health 2024
Clearing the air: microcosting the carbon impact of drug-susceptible pulmonary TB treatment. doi:10.5588/ijtld.24.0157 Int J Tuberc Lung Dis 2024
Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air(®). doi:10.1002/clt2.12390 Clin Transl Allergy 2024
Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. doi:10.1016/S1474-4422(24)00369-7 Lancet Neurol 2024
Contribution of machine learning for subspecies identification from Mycobacterium abscessus with MALDI-TOF MS in solid and liquid media. doi:10.1111/1751-7915.14545 Microb Biotechnol 2024
Evaluation of HIV antiretroviral treatment adherence in 2019 using anonymized data from the French national health insurance claims data base: The COCOVIH study. doi:10.1111/hiv.13690 HIV Med 2024
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis. doi:10.5005/jp-journals-10071-24783 Indian J Crit Care Med 2024
Peripartum Infections: A Position Statement of the Indian Society of Critical Care Medicine. doi:10.5005/jp-journals-10071-24657 Indian J Crit Care Med 2024
Mesenchymal Osr1+ cells regulate embryonic lymphatic vessel formation. doi:10.1242/dev.202747 Development 2024
Deep estimation of the intensity and timing of natural selection from ancient genomes. doi:10.1111/1755-0998.14015 Mol Ecol Resour 2024
Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus. doi:10.1371/journal.ppat.1012440 PLoS Pathog 2024
Tuberculosis in otherwise healthy adults with inherited TNF deficiency. doi:10.1038/s41586-024-07866-3 Nature 2024
An Overview of the Management of Drug-Resistant Tuberculosis in Six French-Speaking African Countries from 2018 to 2022. doi:10.3390/tropicalmed9080176 Trop Med Infect Dis 2024
A Rare Case of Tubercular Osteomyelitis of Mandible in a 5-year-old Child. doi:10.5005/jp-journals-10005-2763 Int J Clin Pediatr Dent 2024
Interferon Gamma in Sickness Predisposing to Mycobacterial Infectious Diseases. doi:10.4274/balkanmedj.galenos.2024.2024-8-18 Balkan Med J 2024
WHO global research priorities for antimicrobial resistance in human health. doi:10.1016/S2666-5247(24)00134-4 Lancet Microbe 2024
Characteristics and Prognosis of Infectious Disease Emergencies in Patients with Chronic Kidney Disease in India. doi:10.5005/jp-journals-10071-24731 Indian J Crit Care Med 2024
Pancreatobiliary Lymphadenopathy: Etiology, Location, and Factors Predicting Good Yield of Endoscopic Ultrasound-guided Biopsy. doi:10.5005/jp-journals-10018-1433 Euroasian J Hepatogastroenterol 2024
Colonoscopy Findings of Uncomplicated Enteric Fever Mimicking Koch's Disease. doi:10.5005/jp-journals-10018-1417 Euroasian J Hepatogastroenterol 2024
Optimization of Mycobacterium tuberculosis DNA processing prior to whole genome sequencing. doi:10.1016/j.tube.2024.102543 Tuberculosis (Edinb) 2024
PPARdelta: A key modulator in the pathogenesis of diabetes mellitus and Mycobacterium tuberculosis co-morbidity. doi:10.1016/j.isci.2024.110046 iScience 2024
Human DNA-dependent protein kinase catalytic subunit deficiency: A comprehensive review and update. doi:10.1016/j.jaci.2024.06.018 J Allergy Clin Immunol 2024
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024). doi:10.1016/j.jaip.2024.06.040 J Allergy Clin Immunol Pract 2024
Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption. doi:10.1093/ofid/ofae327 Open Forum Infect Dis 2024
In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus. doi:10.1093/jac/dkae181 J Antimicrob Chemother 2024
Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? doi:10.3390/ph17060691 Pharmaceuticals (Basel) 2024
Tobacco Use Behaviors and Associated Factors among Newly Diagnosed Tuberculosis Patients in Benin and Burkina Faso. doi:10.3390/tropicalmed9060120 Trop Med Infect Dis 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response. doi:10.1016/j.cmi.2024.06.009 Clin Microbiol Infect 2024
Adolescent BCG revaccination induces a phenotypic shift in CD4(+) T cell responses to Mycobacterium tuberculosis. doi:10.1038/s41467-024-49050-1 Nat Commun 2024
Fe-S biogenesis by SMS and SUF pathways: A focus on the assembly step. doi:10.1016/j.bbamcr.2024.119772 Biochim Biophys Acta Mol Cell Res 2024
Clinical features and treatment outcomes of bone and joint nontuberculous mycobacterial infections according to immune status: a 9-year retrospective observational cohort. doi:10.1016/j.ijid.2024.107122 Int J Infect Dis 2024
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study. doi:10.1002/clt2.12358 Clin Transl Allergy 2024
Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database. doi:10.1002/jmv.29682 J Med Virol 2024
Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial. doi:10.1016/S2214-109X(24)00062-7 Lancet Glob Health 2024
Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy. doi:10.1038/s41467-024-48269-2 Nat Commun 2024
Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiation. doi:10.1016/j.ijid.2024.107096 Int J Infect Dis 2024
Genomic and phenotypic characterization of Mycobacterium tuberculosis' closest-related non-tuberculous mycobacteria. doi:10.1128/spectrum.04126-23 Microbiol Spectr 2024
Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. doi:10.1016/j.eclinm.2024.102528 EClinicalMedicine 2024
A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection. doi:10.1371/journal.pbio.3002259 PLoS Biol 2024
Loss of circulating CD8α(+) NK cells during human Mycobacterium tuberculosis infection. doi:10.1101/2024.04.16.588542 bioRxiv 2024
Successful rescue TNF-α blocking for Mycobacterium genavense - Related immune reconstitution inflammatory syndrome: A case report. doi:10.1016/j.heliyon.2024.e29341 Heliyon 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). doi:10.1183/13993003.01689-2023 Eur Respir J 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). doi:10.1183/13993003.01554-2023 Eur Respir J 2024
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo. doi:10.5588/ijtld.23.0427 Int J Tuberc Lung Dis 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe. doi:10.1016/j.cmi.2024.03.009 Clin Microbiol Infect 2024
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. doi:10.1093/ofid/ofae035 Open Forum Infect Dis 2024
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals. doi:10.1172/JCI178263 J Clin Invest 2024
All you want to know about Mycobacterium abscessus. doi:10.1016/j.cmi.2024.02.019 Clin Microbiol Infect 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC). doi:10.1016/j.jaci.2024.01.027 J Allergy Clin Immunol 2024
Characteristics, management, and outcome of tuberculosis after liver transplant: A case series and literature review. doi:10.1016/j.idnow.2024.104869 Infect Dis Now 2024
Simplified Criteria to Assess Long-Term Antiviral Treatment Indication in Chronic HBV-Infected Pregnant Women in Cambodia. doi:10.3390/v16020194 Viruses 2024
Evolution and emergence of Mycobacterium tuberculosis. doi:10.1093/femsre/fuae006 FEMS Microbiol Rev 2024
Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency. doi:10.1007/s10875-024-01661-5 J Clin Immunol 2024
Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review. doi:10.1016/j.jaci.2024.01.021 J Allergy Clin Immunol 2024
International reproducibility study of thymic epithelial tumors staging: pT stage is an issue. proposals for improvement. A RYTHMIC/ITMIG study. doi:10.1016/j.lungcan.2024.107479 Lung Cancer 2024
Laryngeal tuberculosis in the early 21st century. Literature review of clinical, diagnostic and therapeutic data, according to SWiM guidelines. doi:10.1016/j.anorl.2024.01.001 Eur Ann Otorhinolaryngol Head Neck Dis 2024
Mycobacterium avium complex pulmonary disease patients with limited treatment options. doi:10.1183/23120541.00610-2023 ERJ Open Res 2024
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. doi:10.1186/s13073-023-01278-0 Genome Med 2024
Human inherited CCR2 deficiency underlies progressive polycystic lung disease. doi:10.1016/j.cell.2023.11.036 Cell 2024
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry. doi:10.1136/ard-2023-224819 Ann Rheum Dis 2024
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections. doi:10.1016/j.cmi.2023.09.019 Clin Microbiol Infect 2024
Appeal from the European tuberculosis reference laboratory network (ERLTB-Net) for improving the diagnosis of infections due to nontuberculous mycobacteria. doi:10.1016/j.cmi.2023.06.005 Clin Microbiol Infect 2024
Secondary Spontaneous Pneumothorax in Patients with Silicosis. doi:10.59556/japi.71.0348 J Assoc Physicians India 2023
Global Burden of Cardiovascular Diseases and Risks, 1990-2022. doi:10.1016/j.jacc.2023.11.007 J Am Coll Cardiol 2023
Towards the reconstruction of a global TB history using a new pipeline "TB-Annotator". doi:10.1016/j.tube.2023.102376 Tuberculosis (Edinb) 2023
Paleopathology and evolution of tuberculosis editorial. doi:10.1016/j.tube.2023.102428 Tuberculosis (Edinb) 2023
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery. doi:10.3390/ph16111559 Pharmaceuticals (Basel) 2023
Genome-wide detection of human intronic AG-gain variants located between splicing branchpoints and canonical splice acceptor sites. doi:10.1073/pnas.2314225120 Proc Natl Acad Sci U S A 2023
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria. doi:10.1016/j.cell.2023.09.024 Cell 2023
Mycobacterium tuberculosis complex drug-resistance, phylogenetics, and evolution in Nigeria: Comparison with Ghana and Cameroon. doi:10.1371/journal.pntd.0011619 PLoS Negl Trop Dis 2023
Human inborn errors of immunity associated with IRF4. doi:10.3389/fimmu.2023.1236889 Front Immunol 2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease. doi:10.5588/ijtld.23.0248 Int J Tuberc Lung Dis 2023
[Cushing's syndrome with inhaled corticosteroid: Drug interactions to avoid]. doi:10.1016/j.rmr.2023.07.005 Rev Mal Respir 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy. doi:10.23736/S2724-6051.23.05418-6 Minerva Urol Nephrol 2023
Eukaryotic-like gephyrin and cognate membrane receptor coordinate corynebacterial cell division and polar elongation. doi:10.1038/s41564-023-01473-0 Nat Microbiol 2023
Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks. doi:10.1016/j.isci.2023.107422 iScience 2023
High resolution cryo-EM and crystallographic snapshots of the actinobacterial two-in-one 2-oxoglutarate dehydrogenase. doi:10.1038/s41467-023-40253-6 Nat Commun 2023
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial. doi:10.1016/S2352-3018(23)00113-3 Lancet HIV 2023
Natural mutations in the sensor kinase of the PhoPR two-component regulatory system modulate virulence of ancestor-like tuberculosis bacilli. doi:10.1371/journal.ppat.1011437 PLoS Pathog 2023
Comparison of in silico predicted Mycobacterium tuberculosis spoligotypes and lineages from whole genome sequencing data. doi:10.1038/s41598-023-38384-3 Sci Rep 2023
Tuberculosis in 0-5-year-old children following TB contact investigations: a retrospective study in a low burden setting. doi:10.3389/fped.2023.1145191 Front Pediatr 2023
From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone. doi:10.3390/toxins15060369 Toxins (Basel) 2023
Diagnosis and Treatment of Gordonia Species Infection in a Peach-Faced Lovebird (Agapornis roseicollis). doi:10.1647/20-00013 J Avian Med Surg 2023
Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep. doi:10.1016/j.ebiom.2023.104649 EBioMedicine 2023
Inappropriate antibiotic prescribing and its determinants among outpatient children in 3 low- and middle-income countries: A multicentric community-based cohort study. doi:10.1371/journal.pmed.1004211 PLoS Med 2023
Mycobacterium canettii Tuberculosis Lymphadenopathy in a 3-Year-old Child. doi:10.1097/INF.0000000000003983 Pediatr Infect Dis J 2023
Bacterial, fungal and parasitic co-infections in leprosy: A scoping review. doi:10.1371/journal.pntd.0011334 PLoS Negl Trop Dis 2023
A local subset of mesenchymal cells expressing the transcription factor Osr1 orchestrates lymph node initiation. doi:10.1016/j.immuni.2023.04.014 Immunity 2023
Country of birth is associated with antiretroviral therapy choice in treatment-naive persons with HIV in France. doi:10.1097/QAD.0000000000003588 AIDS 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). doi:10.1016/S2213-2600(23)00093-0 Lancet Respir Med 2023
Stillbirths and neonatal mortality in LMICs: A community-based mother-infant cohort study. doi:10.7189/jogh.13.04031 J Glob Health 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report. doi:10.1111/all.15740 Allergy 2023
Vaccination Coverage and Risk Factors Associated With Incomplete Vaccination Among Children in Cambodia, Madagascar, and Senegal. doi:10.1093/ofid/ofad136 Open Forum Infect Dis 2023
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. doi:10.1186/s13073-023-01173-8 Genome Med 2023
Impact of Deprivation on the Incidence and Severity of Tuberculosis in Children: A Retrospective Study from 2007 to 2020 in a Tertiary Care Center in Paris, France. doi:10.1016/j.jpeds.2023.113395 J Pediatr 2023
Allele-dependent interaction of LRRK2 and NOD2 in leprosy. doi:10.1371/journal.ppat.1011260 PLoS Pathog 2023
Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries. doi:10.1097/QAD.0000000000003521 AIDS 2023
Tirap controls Mycobacterium tuberculosis phagosomal acidification. doi:10.1371/journal.ppat.1011192 PLoS Pathog 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. doi:10.1016/S1473-3099(22)00875-1 Lancet Infect Dis 2023
Inborn errors of human transcription factors governing IFN-γ antimycobacterial immunity. doi:10.1016/j.coi.2023.102296 Curr Opin Immunol 2023
Protocol for multi-modal single-cell RNA sequencing on M. tuberculosis-infected mouse lungs. doi:10.1016/j.xpro.2023.102102 STAR Protoc 2023
Click-chemistry-based protocol to quantitatively assess fatty acid uptake by Mycobacterium tuberculosis in axenic culture and inside mouse macrophages. doi:10.1016/j.xpro.2023.102062 STAR Protoc 2023
Performances of bioinformatics tools for the analysis of sequencing data of Mycobacterium tuberculosis complex strains. doi:10.1016/j.tube.2023.102324 Tuberculosis (Edinb) 2023
Complement regulatory proteins: Candidate biomarkers in differentiating tuberculosis pleural effusion. doi:10.3389/fimmu.2023.1073884 Front Immunol 2023
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. doi:10.1016/j.cmi.2023.02.007 Clin Microbiol Infect 2023
Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit. doi:10.1017/ice.2022.263 Infect Control Hosp Epidemiol 2023
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis. doi:10.1111/all.15679 Allergy 2023
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial. doi:10.1093/cid/ciad070 Clin Infect Dis 2023
Eukaryotic-like gephyrin and cognate membrane receptor coordinate corynebacterial cell division and polar elongation. doi:10.1101/2023.02.01.526586 bioRxiv 2023
Human IL-23 is essential for IFN-γ-dependent immunity to mycobacteria. doi:10.1126/sciimmunol.abq5204 Sci Immunol 2023
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. doi:10.1016/j.cell.2022.12.038 Cell 2023
Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air(®) approach. doi:10.1002/clt2.12215 Clin Transl Allergy 2023
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. doi:10.1136/ard-2022-223595 Ann Rheum Dis 2023
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds. doi:10.1007/s10875-022-01419-x J Clin Immunol 2023
Atypical presentation of Mycobacterium xenopi pulmonary infection in a kidney transplant recipient: A case report and literature review. doi:10.1016/j.idcr.2022.e01675 IDCases 2023
[Choroidal granuloma in miliary tuberculosis; a case report]. doi:10.1016/j.jfo.2022.06.019 J Fr Ophtalmol 2023
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis. doi:10.1084/jem.20220484 J Exp Med 2023
Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency. doi:10.1007/s10875-022-01374-7 J Clin Immunol 2023
Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico. doi:10.1007/s10875-022-01357-8 J Clin Immunol 2023
Infectious Crystalline Keratopathy Secondary to Mycobacterium chelonae. doi:10.1097/ICO.0000000000003125 Cornea 2023
Programmatic Implementation of Contact Investigation in Eight African Countries. doi:10.3390/tropicalmed8010029 Trop Med Infect Dis 2022
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses. doi:10.3389/fimmu.2022.897193 Front Immunol 2022
Investigating the Diversity of Tuberculosis Spoligotypes with Dimensionality Reduction and Graph Theory. doi:10.3390/genes13122328 Genes (Basel) 2022
Author Correction: A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome. doi:10.1038/s41467-022-35402-2 Nat Commun 2022
FtsEX-independent control of RipA-mediated cell separation in Corynebacteriales. doi:10.1073/pnas.2214599119 Proc Natl Acad Sci U S A 2022
Characteristics of the GlnH and GlnX Signal Transduction Proteins Controlling PknG-Mediated Phosphorylation of OdhI and 2-Oxoglutarate Dehydrogenase Activity in Corynebacterium glutamicum. doi:10.1128/spectrum.02677-22 Microbiol Spectr 2022
Early risk assessment in paediatric and adult household contacts of confirmed tuberculosis cases by novel diagnostic tests (ERASE-TB): protocol for a prospective, non-interventional, longitudinal, multicountry cohort study. doi:10.1136/bmjopen-2022-060985 BMJ Open 2022
A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome. doi:10.1038/s41467-022-34853-x Nat Commun 2022
Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening. doi:10.1039/d2sc02371g Chem Sci 2022
Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience. doi:10.1093/ofid/ofac465 Open Forum Infect Dis 2022
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria. doi:10.3389/fimmu.2022.888427 Front Immunol 2022
A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4(+) T-cell immunity. doi:10.1038/s41385-022-00566-z Mucosal Immunol 2022
Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. doi:10.1084/jem.20220094 J Exp Med 2022
Fit to dwell in many places - The growing diversity of intracellular Salmonella niches. doi:10.3389/fcimb.2022.989451 Front Cell Infect Microbiol 2022
In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India. doi:10.5005/jp-journals-10018-1371 Euroasian J Hepatogastroenterol 2022
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. doi:10.1016/j.cell.2022.07.004 Cell 2022
Respiratory Tract Infections in Diabetes - Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity. doi:10.3389/fendo.2022.919223 Front Endocrinol (Lausanne) 2022
Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis. doi:10.1128/aac.02357-21 Antimicrob Agents Chemother 2022
A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4(+) T cell immunity. doi:10.1016/j.celrep.2022.111142 Cell Rep 2022
Unique Challenges Faced by a Child with Standard Risk Leukemia in Post-COVID Era: A Case Report. doi:10.5005/jp-journals-10071-24236 Indian J Crit Care Med 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. doi:10.1002/art.42282 Arthritis Rheumatol 2022
Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy. doi:10.1002/jcla.24579 J Clin Lab Anal 2022
Low-cost anti-mycobacterial drug discovery using engineered E. coli. doi:10.1038/s41467-022-31570-3 Nat Commun 2022
Diagnostic toolkit for tuberculosis: should we include urine lipoarabinomannan (LAM) detection in the WHO European Region? doi:10.1016/j.cmi.2022.06.022 Clin Microbiol Infect 2022
Aural tuberculosis at the start of the 21st century. Literature review according to SWiM guidelines. Part 2: Treatment. doi:10.1016/j.anorl.2022.06.007 Eur Ann Otorhinolaryngol Head Neck Dis 2022
Burden of and risk factors for sexual violence among women with and without disabilities in two sub-Saharan African countries. doi:10.1080/16549716.2022.2077904 Glob Health Action 2022
Comparing Important and Well-documented Potential Drug-Drug Interactions between Emergency, Medical, and Surgical ICUs of a Respiratory Referral Center. doi:10.5005/jp-journals-10071-23902 Indian J Crit Care Med 2022
Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study. doi:10.1016/S2214-109X(22)00174-7 Lancet Glob Health 2022
Aural tuberculosis at the start of the 21st century. Literature review according to SWiM guidelines. Part 1: Clinical and diagnostic data. doi:10.1016/j.anorl.2022.05.005 Eur Ann Otorhinolaryngol Head Neck Dis 2022
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency. doi:10.1084/jem.20220202 J Exp Med 2022
Story of an Abscess: A Case of Mycobacterium abscessus Infection in an Immunocompetent Patient. doi:10.5005/jp-journals-10071-24182 Indian J Crit Care Med 2022
Undernutrition can no longer be an afterthought for global efforts to eliminate TB. doi:10.5588/ijtld.22.0197 Int J Tuberc Lung Dis 2022
Functionalized Nitroimidazole Scaffold Construction and Their Pharmaceutical Applications: A 1950-2021 Comprehensive Overview. doi:10.3390/ph15050561 Pharmaceuticals (Basel) 2022
Musculoskeletal tuberculosis in Bradford : 12 years of outcomes and observations in a high-incidence region of the UK. doi:10.1302/2633-1462.35.BJO-2021-0200.R1 Bone Jt Open 2022
Update on the Coordinated Efforts of Looking After the Health Care Needs of Children and Young People Fleeing the Conflict Zone of Ukraine Presenting to European Emergency Departments-A Joint Statement of the European Society for Emergency Paediatrics and the European Academy of Paediatrics. doi:10.3389/fped.2022.897803 Front Pediatr 2022
Intracellular niche switching as host subversion strategy of bacterial pathogens. doi:10.1016/j.ceb.2022.102081 Curr Opin Cell Biol 2022
Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries. doi:10.3390/pathogens11020196 Pathogens 2022
Diagnostic yield of image-guided biopsy in patients with suspected infectious spondylodiscitis : a prospective study from a tuberculosis-endemic country. doi:10.1302/0301-620X.104B1.BJJ-2021-0848.R2 Bone Joint J 2022
Fungal and mycobacterial cultures should not be routinely obtained for diagnostic work-up of patients with suspected periprosthetic joint infections. doi:10.1302/0301-620X.104B1.BJJ-2021-0876.R1 Bone Joint J 2022
Characteristics of children with leprosy: Factors associated with delay in disease diagnosis. doi:10.25259/IJDVL_1382_20 Indian J Dermatol Venereol Leprol 2022
Early Experience of High-dose Intravenous Mycobacterium w in Critically Ill Patients of COVID-19. doi:10.5005/jp-journals-10071-23963 Indian J Crit Care Med 2021
De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis. doi:10.7554/eLife.71946 Elife 2021
Deep resequencing identifies candidate functional genes in leprosy GWAS loci. doi:10.1371/journal.pntd.0010029 PLoS Negl Trop Dis 2021
Cytokine Storm and Immunomodulation in COVID-19. doi:10.5005/jp-journals-10071-24029 Indian J Crit Care Med 2021
Massive Cerebral Air Embolism Causing Stroke Secondary to Pulmonary Tuberculosis. doi:10.5005/jp-journals-10071-23933 Indian J Crit Care Med 2021
Tuberculosis in Intensive Care Unit. doi:10.5005/jp-journals-10071-23872 Indian J Crit Care Med 2021
Laboratory Diagnosis of Tropical Infections. doi:10.5005/jp-journals-10071-23813 Indian J Crit Care Med 2021
Radiographical Spectrum of High-altitude Pulmonary Edema: A Pictorial Essay. doi:10.5005/jp-journals-10071-23827 Indian J Crit Care Med 2021
Clinical Features and Outcomes of Very Elderly Patients Admitted to the Intensive Care Unit: A Retrospective and Observational Study. doi:10.5005/jp-journals-10071-23846 Indian J Crit Care Med 2021
A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance. doi:10.1016/j.cmi.2021.07.007 Clin Microbiol Infect 2021
Anaphylatoxins orchestrate Th17 response via interactions between CD16+ monocytes and pleural mesothelial cells in tuberculous pleural effusion. doi:10.1371/journal.pntd.0009508 PLoS Negl Trop Dis 2021
First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn? doi:10.3390/molecules26123708 Molecules 2021
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction. doi:10.1038/s42003-021-02251-6 Commun Biol 2021
Safe Polycationic Dendrimers as Potent Oral In Vivo Inhibitors of Mycobacterium tuberculosis: A New Therapy to Take Down Tuberculosis. doi:10.1021/acs.biomac.1c00355 Biomacromolecules 2021
Defining mechanical instability in tuberculosis of the spine: a systematic review. doi:10.1302/2058-5241.6.200113 EFORT Open Rev 2021
Surgeon-directed transcranial motor evoked potential spinal cord monitoring in spinal deformity surgery. doi:10.1302/0301-620X.103B3.BJJ-2020-1278.R1 Bone Joint J 2021
Clinical Profile and Outcome of Critically Ill Patients with Tuberculosis. doi:10.5005/jp-journals-10071-23503 Indian J Crit Care Med 2021
Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis. doi:10.1111/imr.12952 Immunol Rev 2021
Synthesis of Carbapenems Containing Peptidoglycan Mimetics and Inhibition of the Cross-Linking Activity of a Transpeptidase of l,d Specificity. doi:10.1002/chem.202004831 Chemistry 2021
COVID-19 Pneumonia with Delayed Viral Clearance in a Patient with Active Drug-resistant Pulmonary Tuberculosis. doi:10.5005/jp-journals-10071-23662 Indian J Crit Care Med 2020
Spatiotemporal analysis of mycolactone distribution in vivo reveals partial diffusion in the central nervous system. doi:10.1371/journal.pntd.0008878 PLoS Negl Trop Dis 2020
Corrigendum: CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs. doi:10.3389/fcimb.2020.587907 names it Front Cell Infect Microbiol 2020
The mNCP-SPI Score Predicting Risk of Severe COVID-19 among Mild-Pneumonia Patients on Admission. doi:10.2147/IDR.S263157 Infect Drug Resist 2020
COVID-19 in Africa: community and digital technologies for tuberculosis management. doi:10.5588/ijtld.20.0412 Int J Tuberc Lung Dis 2020
[Health issues in precarious people]. Rev Prat 2020
Surgical treatment of metastatic diseases to the lung. doi:10.5114/kitp.2020.97254 Kardiochir Torakochirurgia Pol 2020
Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases. doi:10.3389/fmicb.2020.01248 Front Microbiol 2020
Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta-analysis. doi:10.1002/ppul.24913 Pediatr Pulmonol 2020
An Observational Study of QTc Prolongation in Critically Ill Patients: Identification of Incidence and Predictors. doi:10.5005/jp-journals-10071-23411 Indian J Crit Care Med 2020
The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection. doi:10.7554/eLife.55692 Elife 2020
Tuberculosis trends in a hot-spot region in Paris, France. doi:10.5588/ijtld.19.0305 Int J Tuberc Lung Dis 2020
Citrate lyase CitE in Mycobacterium tuberculosis contributes to mycobacterial survival under hypoxic conditions. doi:10.1371/journal.pone.0230786 names it PLoS One 2020
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries. doi:10.1016/j.eclinm.2020.100268 EClinicalMedicine 2020
ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs. doi:10.5005/jp-journals-10071-G23186 Indian J Crit Care Med 2020
Tuberculosis and Tumor Lysis Syndrome-Coincidence or Coexistent: A Case Report. doi:10.5005/jp-journals-10071-23359 Indian J Crit Care Med 2020
Hemophagocytic Lymphohistiocytosis Related to Tuberculosis Disease. doi:10.5005/jp-journals-10071-23329 Indian J Crit Care Med 2020
Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection. doi:10.1126/sciadv.aax7781 Sci Adv 2020
Management of HIV-infected patients in the intensive care unit. doi:10.1007/s00134-020-05945-3 Intensive Care Med 2020
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study. doi:10.5588/ijtld.19.0856 Int J Tuberc Lung Dis 2020
Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit. doi:10.5588/ijtld.19.0221 Int J Tuberc Lung Dis 2020
Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence. doi:10.3390/jcm9010055 J Clin Med 2019
Prognostic factors for unfavourable outcomes of patients with spinal tuberculosis in a country with an intermediate tuberculosis burden: a multicentre cohort study. doi:10.1302/0301-620X.101B12.BJJ-2019-0558.R1 Bone Joint J 2019
Culture-negative periprosthetic joint infections. doi:10.1302/2058-5241.4.180067 EFORT Open Rev 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). doi:10.1002/eji.201970107 Eur J Immunol 2019
Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress. doi:10.15252/embj.2019101876 EMBO J 2019
High Activation of γδ T Cells and the γδ2(pos) T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK. doi:10.3389/fimmu.2019.02018 Front Immunol 2019
Results of a pilot study of isoniazid in patients with erythropoietic protoporphyria. doi:10.1016/j.ymgme.2019.07.017 Mol Genet Metab 2019
Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype. doi:10.1371/journal.ppat.1007945 PLoS Pathog 2019
An essential bifunctional enzyme in Mycobacterium tuberculosis for itaconate dissimilation and leucine catabolism. doi:10.1073/pnas.1906606116 Proc Natl Acad Sci U S A 2019
Tuberculosis and Short Bowel: A Therapeutic Challenge. doi:10.5005/jp-journals-10071-23157 Indian J Crit Care Med 2019
First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria. doi:10.1016/j.jgar.2019.05.010 J Glob Antimicrob Resist 2019
Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis. doi:10.1016/j.medmal.2019.03.002 Med Mal Infect 2019
Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens. doi:10.5588/ijtld.18.0798 Int J Tuberc Lung Dis 2019
Tryptophan Fluorescence Quenching in β-Lactam-Interacting Proteins Is Modulated by the Structure of Intermediates and Final Products of the Acylation Reaction. doi:10.1021/acsinfecdis.9b00023 ACS Infect Dis 2019
Impact of HIV on spontaneous spondylodiscitis. doi:10.1302/0301-620X.101B5.BJJ-2018-0960.R1 Bone Joint J 2019
[Infectious complications after kidney transplantation]. doi:10.1016/j.nephro.2019.03.010 Nephrol Ther 2019
[Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment]. doi:10.1016/j.annder.2019.01.010 Ann Dermatol Venereol 2019
The crystal structure of Rv2991 from Mycobacterium tuberculosis: An F(420) binding protein with unknown function. doi:10.1016/j.jsb.2019.03.006 J Struct Biol 2019
The role of histology in the diagnosis of spondylodiscitis: correlation with clinical and microbiological findings. doi:10.1302/0301-620X.101B3.BJJ-2018-0491.R2 Bone Joint J 2019
Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. doi:10.5588/ijtld.18.0207 Int J Tuberc Lung Dis 2019
Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. doi:10.1183/13993003.01660-2018 Eur Respir J 2019
Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity. doi:10.1016/j.str.2019.01.004 Structure 2019
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection. doi:10.1186/s12951-018-0439-x J Nanobiotechnology 2019
Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis. doi:10.5588/ijtld.18.0042 Int J Tuberc Lung Dis 2019
Towards better management of latent tuberculosis infection in children and young adults in the Maghreb. Conclusions of an expert meeting, Paris, 16 March 2018. doi:10.1016/j.arcped.2018.12.001 Arch Pediatr 2019
Familial Blau syndrome:First molecularly confirmed report from India. doi:10.4103/ijo.IJO_671_18 Indian J Ophthalmol 2019
An international perspective on hospitalized patients with viral community-acquired pneumonia. doi:10.1016/j.ejim.2018.10.020 Eur J Intern Med 2019
Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence. doi:10.3389/fmicb.2018.03072 Front Microbiol 2018
CitE Enzymes Are Essential for Mycobacterium tuberculosis to Establish Infection in Macrophages and Guinea Pigs. doi:10.3389/fcimb.2018.00385 names it Front Cell Infect Microbiol 2018
Reactivation of dormant/latent fungal infection. doi:10.1016/j.jinf.2018.06.016 J Infect 2018
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment. doi:10.5588/ijtld.18.0423 Int J Tuberc Lung Dis 2018
[Interferon gamma release assay tests for the diagnosis of latent and active tuberculosis in hemodialysis patients or solid organ transplant recipients]. doi:10.1016/j.rmr.2018.08.015 Rev Mal Respir 2018
Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015. doi:10.1371/journal.pone.0203438 PLoS One 2018
Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making. doi:10.1038/s41541-018-0075-3 NPJ Vaccines 2018
[Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis]. doi:10.1016/j.rmr.2018.08.007 Rev Mal Respir 2018
Author Correction: Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis. doi:10.1038/s41598-018-31948-8 Sci Rep 2018
A scoping review on the field validation and implementation of rapid diagnostic tests for vector-borne and other infectious diseases of poverty in urban areas. doi:10.1186/s40249-018-0474-8 Infect Dis Poverty 2018
The posterior-only surgical approach in the treatment of tuberculosis of the spine: outcomes using cortical bone allografts. doi:10.1302/0301-620X.100B9.BJJ-2017-1326.R2 Bone Joint J 2018
Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study. doi:10.1186/s13054-018-2140-8 Crit Care 2018
Structure of the essential peptidoglycan amidotransferase MurT/GatD complex from Streptococcus pneumoniae. doi:10.1038/s41467-018-05602-w Nat Commun 2018
New Ways to Treat Tuberculosis Using Dendrimers as Nanocarriers. doi:10.3390/pharmaceutics10030105 Pharmaceutics 2018
Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis. doi:10.1016/j.medmal.2018.06.006 Med Mal Infect 2018
A Variety of Alu-Mediated Copy Number Variations Can Underlie IL-12Rβ1 Deficiency. doi:10.1007/s10875-018-0527-6 J Clin Immunol 2018
F-18 Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography Findings of Isolated Gastric Tuberculosis mimicking Gastric Cancer and Lymphoma. doi:10.5005/jp-journals-10018-1270 Euroasian J Hepatogastroenterol 2018
Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. doi:10.1016/j.cmi.2018.06.004 Clin Microbiol Infect 2018
[Ocular tuberculosis]. doi:10.1016/j.revmed.2018.05.003 Rev Med Interne 2018
Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. doi:10.1111/tid.12943 Transpl Infect Dis 2018
In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus. doi:10.1128/AAC.00623-18 Antimicrob Agents Chemother 2018
Granuloma of the labial minor salivary glands in tuberculosis. doi:10.4103/jomfp.JOMFP_137_15 J Oral Maxillofac Pathol 2018
Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer. doi:10.1371/journal.pntd.0006429 PLoS Negl Trop Dis 2018
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia. doi:10.1159/000487713 Respiration 2018
Spinal tuberculosis: review of current management. doi:10.1302/0301-620X.100B4.BJJ-2017-1040.R1 Bone Joint J 2018
Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria. doi:10.1002/chem.201800923 Chemistry 2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. doi:10.1183/13993003.00170-2018 Eur Respir J 2018
Critical Impact of Peptidoglycan Precursor Amidation on the Activity of l,d-Transpeptidases from Enterococcus faecium and Mycobacterium tuberculosis. doi:10.1002/chem.201706082 Chemistry 2018
Cutaneous Granulomatosis: a Comprehensive Review. doi:10.1007/s12016-017-8666-8 Clin Rev Allergy Immunol 2018
Delays in the diagnosis and treatment of bone and joint tuberculosis in the United Kingdom. doi:10.1302/0301-620X.100B1.BJJ-2017-0357.R1 Bone Joint J 2018
Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study. doi:10.3899/jrheum.170520 J Rheumatol 2018
In vitro activity of tedizolid against the Mycobacterium abscessus complex. doi:10.1016/j.diagmicrobio.2017.11.001 Diagn Microbiol Infect Dis 2018
B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis. doi:10.1164/rccm.201707-1475OC Am J Respir Crit Care Med 2018
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries. doi:10.5588/ijtld.17.0498 Int J Tuberc Lung Dis 2018
Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children With Active Tuberculosis in France. doi:10.1097/INF.0000000000001774 Pediatr Infect Dis J 2018
Pleural tuberculosis under rituximab therapy for anti-synthetase syndrome. doi:10.1080/03009742.2017.1340514 Scand J Rheumatol 2018
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation. doi:10.1016/j.cmi.2017.06.016 Clin Microbiol Infect 2018
Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area. doi:10.5588/ijtld.17.0353 Int J Tuberc Lung Dis 2017
Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked. doi:10.5005/jp-journals-10018-1224 Euroasian J Hepatogastroenterol 2017
Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection. doi:10.3389/fimmu.2017.01533 Front Immunol 2017
Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis. doi:10.1038/s41598-017-16250-3 Sci Rep 2017
Acute Septic Arthritis of the Knee Caused by Kingella kingae in a 5-Year-Old Cameroonian Boy. doi:10.3389/fped.2017.00230 Front Pediatr 2017
An eQTL variant of ZXDC is associated with IFN-γ production following Mycobacterium tuberculosis antigen-specific stimulation. doi:10.1038/s41598-017-13017-8 Sci Rep 2017
Tuberculosis of the spine with severe angular kyphosis: mean 34-year post-operative follow-up shows that prevention is better than salvage. doi:10.1302/0301-620X.99B10.BJJ-2017-0148.R1 Bone Joint J 2017
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion. doi:10.2459/JCM.0000000000000576 J Cardiovasc Med (Hagerstown) 2017
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. doi:10.1136/bmjopen-2016-014608 BMJ Open 2017
Immune response in Takayasu arteritis. doi:10.1016/j.lpm.2017.07.002 Presse Med 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort. doi:10.1111/jdv.14406 J Eur Acad Dermatol Venereol 2017
Cytokine/chemokine secretion for detecting tuberculosis in quantiferon supernatants from HIV(+) and HIV(-) children. doi:10.1016/j.jinf.2017.04.009 J Infect 2017
Tuberculosis in children with sickle cell anaemia: a retrospective study in French tertiary care centres. doi:10.1007/s00431-017-2905-0 Eur J Pediatr 2017
Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities. doi:10.1016/j.ijid.2016.10.012 Int J Infect Dis 2017
Management of adult infectious encephalitis in metropolitan France. doi:10.1016/j.medmal.2017.01.006 Med Mal Infect 2017
Pathogenic and immunosuppressive properties of mycobacterial phenolic glycolipids. doi:10.1016/j.biochi.2017.03.012 Biochimie 2017
Adnexal masses associated with peritoneal involvement: diagnosis with CT and MRI. doi:10.1007/s00261-017-1089-4 Abdom Radiol (NY) 2017
Infectious encephalitis: Management without etiological diagnosis 48hours after onset. doi:10.1016/j.medmal.2017.02.004 Med Mal Infect 2017
In reply. doi:10.5588/ijtld.17.0025-4 Int J Tuberc Lung Dis 2017
Relevance of diagnostic investigations in patients with uveitis: Retrospective cohort study on 300 patients. doi:10.1016/j.autrev.2017.03.006 Autoimmun Rev 2017
New insights on tuberculous aortitis. doi:10.1016/j.jvs.2016.11.045 J Vasc Surg 2017
Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients. doi:10.1016/j.jinf.2017.01.016 J Infect 2017
Mass-forming lesions of the duodenum: A pictorial review. doi:10.1016/j.diii.2017.01.004 Diagn Interv Imaging 2017
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors. doi:10.1183/13993003.01719-2016 Eur Respir J 2017
Do active case-finding projects increase the number of tuberculosis cases notified at national level? doi:10.5588/ijtld.16.0653 Int J Tuberc Lung Dis 2017
Inhibition of the β-Lactamase Bla(Mab) by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus. doi:10.1128/AAC.02440-16 Antimicrob Agents Chemother 2017
The crystal structure of PknI from Mycobacterium tuberculosis shows an inactive, pseudokinase-like conformation. doi:10.1111/febs.14003 FEBS J 2017
Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate. doi:10.1093/jac/dkw546 J Antimicrob Chemother 2017
Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. doi:10.1016/j.jaci.2016.09.035 J Allergy Clin Immunol 2017
Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities. doi:10.3201/eid2302.152042 Emerg Infect Dis 2017
Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures. doi:10.1016/j.jinf.2016.11.014 J Infect 2017
Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives. doi:10.1016/j.cmi.2016.10.022 Clin Microbiol Infect 2017
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study. doi:10.1136/annrheumdis-2016-210094 Ann Rheum Dis 2017
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. doi:10.1128/AAC.00943-16 Antimicrob Agents Chemother 2017
Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria. doi:10.1016/j.cmi.2016.09.006 Clin Microbiol Infect 2017
[Opportunistic infections and sarcoidosis]. doi:10.1016/j.revmed.2016.08.011 Rev Med Interne 2017
Multinodule abnormalities of the tracheobronchus: bronchoscopy findings and clinical diagnosis. doi:10.1111/crj.12356 Clin Respir J 2017
[Clinical comparative analysis for pulmonary histoplasmosis and progressive disseminated histoplasmosis]. doi:10.11817/j.issn.1672-7347.2016.12.016 Zhong Nan Da Xue Xue Bao Yi Xue Ban 2016
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. doi:10.1186/s13601-016-0137-4 Clin Transl Allergy 2016
IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis. doi:10.3389/fimmu.2016.00465 Front Immunol 2016
The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. doi:10.1016/j.tube.2016.09.028 Tuberculosis (Edinb) 2016
Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. doi:10.1084/jem.20160576 J Exp Med 2016
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. doi:10.1080/14787210.2016.1238304 Expert Rev Anti Infect Ther 2016
Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. doi:10.1183/13993003.00457-2016 Eur Respir J 2016
Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. doi:10.1038/srep33162 Sci Rep 2016
Immune response to Mycobacterium tuberculosis in young contacts with discordant immunological test results. doi:10.1016/j.jinf.2016.08.013 J Infect 2016
pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence. doi:10.1038/nmicrobiol.2015.19 Nat Microbiol 2016
Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1016/j.tube.2016.06.002 Tuberculosis (Edinb) 2016
[Innate immunity primary immunodeficiencies and infections]. doi:10.1016/j.arcped.2016.04.020 Arch Pediatr 2016
Anterior debridement may not be necessary in the treatment of tuberculous spondylitis of the thoracic and lumbar spine in adults: a retrospective study. doi:10.1302/0301-620X.98B6.36472 Bone Joint J 2016
Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis. doi:10.1093/jac/dkw169 J Antimicrob Chemother 2016
Hybrid Potential Simulation of the Acylation of Enterococcus faecium l,d-Transpeptidase by Carbapenems. doi:10.1021/acs.jpcb.6b02836 J Phys Chem B 2016
Molecular Basis of Membrane Association by the Phosphatidylinositol Mannosyltransferase PimA Enzyme from Mycobacteria. doi:10.1074/jbc.M116.723676 J Biol Chem 2016
Granulomatous Lithiasic Cholecystitis in Sarcoidosis. doi:10.4081/cp.2016.811 Clin Pract 2016
Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar. doi:10.1093/jac/dkw130 J Antimicrob Chemother 2016
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. doi:10.1182/blood-2015-11-679902 Blood 2016
Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion. doi:10.1038/srep24193 Sci Rep 2016
The interplay between regulated necrosis and bacterial infection. doi:10.1007/s00018-016-2206-1 Cell Mol Life Sci 2016
Rifabutin: where do we stand in 2016? doi:10.1093/jac/dkw024 J Antimicrob Chemother 2016
Bedaquiline plus delamanid for XDR tuberculosis. doi:10.1016/S1473-3099(16)00047-5 Lancet Infect Dis 2016
Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015. doi:10.1111/all.12880 Allergy 2016
Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus. doi:10.1093/jac/dkw022 J Antimicrob Chemother 2016
Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis. doi:10.1016/j.ijid.2016.01.004 Int J Infect Dis 2016
Viral Hepatitis in Mongolia: Past, Present, and Future. doi:10.5005/jp-journals-10018-1168 Euroasian J Hepatogastroenterol 2016
Major Loci on Chromosomes 8q and 3q Control Interferon γ Production Triggered by Bacillus Calmette-Guerin and 6-kDa Early Secretory Antigen Target, Respectively, in Various Populations. doi:10.1093/infdis/jiv757 J Infect Dis 2016
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial. doi:10.1093/jac/dkv384 J Antimicrob Chemother 2016
Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS. doi:10.1016/j.jbspin.2015.04.022 Joint Bone Spine 2016
Functional polymorphisms of Monocyte Chemoattractant Protein-1 gene and Pott's disease risk. doi:10.1016/j.imbio.2015.11.004 Immunobiology 2016
[Prevalence of granulomatous lesions in minor salivary gland biopsy in a case series of 65 patients with tuberculosis]. doi:10.1016/j.revmed.2015.07.009 Rev Med Interne 2016
Diagnosis of smear-negative pulmonary tuberculosis based on clinical signs in the Republic of Congo. doi:10.1186/s13104-015-1774-8 BMC Res Notes 2015
Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis. doi:10.1038/srep16918 Sci Rep 2015
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study. doi:10.1371/journal.pone.0140845 PLoS One 2015
Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts. doi:10.1136/rmdopen-2015-000128 RMD Open 2015
New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories. doi:10.1371/journal.pntd.0004141 PLoS Negl Trop Dis 2015
Update on the epidemiology, diagnosis, and treatment of leprosy. doi:10.1016/j.medmal.2015.09.002 Med Mal Infect 2015
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view. doi:10.2217/fmb.15.64 Future Microbiol 2015
Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex. doi:10.1128/AAC.01027-15 Antimicrob Agents Chemother 2015
Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome. doi:10.1084/jem.20140280 J Exp Med 2015
Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country. doi:10.1513/AnnalsATS.201412-600OC Ann Am Thorac Soc 2015
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. doi:10.1126/science.aaa4282 Science 2015
Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment. doi:10.1128/IAI.00418-15 Infect Immun 2015
Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif. doi:10.1128/AAC.00598-15 Antimicrob Agents Chemother 2015
Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS. doi:10.1097/QAD.0000000000000634 AIDS 2015
Acyl acceptor recognition by Enterococcus faecium L,D-transpeptidase Ldtfm. doi:10.1111/mmi.13104 Mol Microbiol 2015
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. doi:10.1016/j.chembiol.2015.05.016 Chem Biol 2015
Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection. doi:10.1128/AAC.01063-15 Antimicrob Agents Chemother 2015
Molecular Basis of the Activity and the Regulation of the Eukaryotic-like S/T Protein Kinase PknG from Mycobacterium tuberculosis. doi:10.1016/j.str.2015.04.001 Structure 2015
Causes of death in the Taabo health and demographic surveillance system, Côte d'Ivoire, from 2009 to 2011. doi:10.3402/gha.v8.27271 Glob Health Action 2015
Altered cytokine profiles in children with indeterminate quantiferon results and common infections. doi:10.1016/j.jinf.2015.03.014 J Infect 2015
A case of postoperative breast infection by Mycobacterium fortuitum associated with the hospital water supply. doi:10.1016/j.ajic.2014.12.023 Am J Infect Control 2015
Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution. doi:10.1097/INF.0000000000000589 Pediatr Infect Dis J 2015
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. doi:10.1016/j.jcf.2015.02.006 J Cyst Fibros 2015
Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus. doi:10.1128/AAC.05080-14 Antimicrob Agents Chemother 2015
Host-microbe interactions in distal airways: relevance to chronic airway diseases. doi:10.1183/09059180.00011614 Eur Respir Rev 2015
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study. doi:10.1017/ice.2015.19 Infect Control Hosp Epidemiol 2015
Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A. doi:10.1107/S139900471402522X Acta Crystallogr D Biol Crystallogr 2015
[Complications of BCG vaccine SSI® in a pediatric hospital: two reported cases]. doi:10.1016/j.lpm.2014.10.015 Presse Med 2015
The crystal structure of the catalytic domain of the ser/thr kinase PknA from M. tuberculosis shows an Src-like autoinhibited conformation. doi:10.1002/prot.24754 Proteins 2015
Abdominal Tuberculosis: A Diagnostic Dilemma. doi:10.5005/jp-journals-10018-1133 Euroasian J Hepatogastroenterol 2015
β-Lactamase inhibition by avibactam in Mycobacterium abscessus. doi:10.1093/jac/dku510 J Antimicrob Chemother 2015
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study. doi:10.1111/hiv.12201 HIV Med 2015
Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice. doi:10.1128/IAI.02032-14 Infect Immun 2015
Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic. doi:10.1128/AAC.03461-14 Antimicrob Agents Chemother 2015
Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis. doi:10.1007/s10875-014-0103-7 J Clin Immunol 2015
Tuberculin skin test negativity is under tight genetic control of chromosomal region 11p14-15 in settings with different tuberculosis endemicities. doi:10.1093/infdis/jiu446 J Infect Dis 2015
Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection. doi:10.1093/infdis/jiu412 J Infect Dis 2015
Structural and functional characterization of an arylamine N-acetyltransferase from the pathogen Mycobacterium abscessus: differences from other mycobacterial isoforms and implications for selective inhibition. doi:10.1107/S1399004714021282 Acta Crystallogr D Biol Crystallogr 2014
Buruli ulcer acquired in Mali: a rare and atypical situation. doi:10.1016/j.tmaid.2014.09.009 Travel Med Infect Dis 2014
HIV infection and Buruli ulcer in Africa. doi:10.1016/S1473-3099(14)70882-5 Lancet Infect Dis 2014
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. doi:10.1016/S2214-109X(14)70223-2 Lancet Glob Health 2014
Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. doi:10.1093/cid/ciu584 Clin Infect Dis 2014
Classification algorithm for subspecies identification within the Mycobacterium abscessus species, based on matrix-assisted laser desorption ionization-time of flight mass spectrometry. doi:10.1128/JCM.00788-14 J Clin Microbiol 2014
Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. doi:10.1371/journal.pntd.0002879 PLoS Negl Trop Dis 2014
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial. doi:10.1016/S1473-3099(14)70711-X Lancet Infect Dis 2014
Association study of genes controlling IL-12-dependent IFN-γ immunity: STAT4 alleles increase risk of pulmonary tuberculosis in Morocco. doi:10.1093/infdis/jiu140 J Infect Dis 2014
Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis. doi:10.1093/infdis/jiu135 J Infect Dis 2014
Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study. doi:10.1016/j.jinf.2013.08.005 J Infect 2014
Functional imaging in extrapulmonary sarcoidosis: FDG-PET/CT and MR features. doi:10.1097/RLU.0b013e318279f264 Clin Nucl Med 2014
atpE gene as a new useful specific molecular target to quantify Mycobacterium in environmental samples. doi:10.1186/1471-2180-13-277 BMC Microbiol 2013
Acute lower respiratory infections on lung sequelae in Cambodia, a neglected disease in highly tuberculosis-endemic country. doi:10.1016/j.rmed.2013.07.018 Respir Med 2013
[Socio-demographic, biological and clinical profile of patients living with HIV during screening in a voluntary counselling and screening centre in a rural area of Mbanza-Ngungu, Democratic Republic of Congo, in 2006-2011]. doi:10.1007/s13149-013-0297-6 Bull Soc Pathol Exot 2013
QuantiFERON to diagnose infection by Mycobacterium tuberculosis: performance in infants and older children. doi:10.1016/j.jinf.2013.06.011 J Infect 2013
Combination prevention: new hope for stopping the epidemic. doi:10.1007/s11904-013-0155-y Curr HIV/AIDS Rep 2013
Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. doi:10.1097/MD.0b013e31828a01f9 Medicine (Baltimore) 2013
Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. doi:10.1016/j.bmc.2012.12.011 Bioorg Med Chem 2013
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. doi:10.4161/onci.20696 Oncoimmunology 2012
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient. doi:10.1099/jmm.0.042739-0 J Med Microbiol 2012
Equilibrium binding and kinetic characterization of putative tetracycline repressor family transcription regulator Fad35R from Mycobacterium tuberculosis. doi:10.1111/j.1742-4658.2012.08707.x FEBS J 2012
Label-free and reagentless electrochemical detection of PCR fragments using self-assembled quinone derivative monolayer: application to Mycobacterium tuberculosis. doi:10.1016/j.bios.2011.11.048 Biosens Bioelectron 2012
[Laboratories "Produits Scientia" and mineral waters from Pougues and Carabana]. Rev Hist Pharm (Paris) 2011
Fighting resistant tuberculosis with old compounds: the carbapenem paradigm. doi:10.1111/j.1469-0691.2011.03699.x Clin Microbiol Infect 2011
Enzyme closure and nucleotide binding structurally lock guanylate kinase. doi:10.1016/j.bpj.2011.07.048 Biophys J 2011
Tuberculosis as a complex trait: impact of genetic epidemiological study design. doi:10.1007/s00335-010-9301-7 Mamm Genome 2011
Development of a real-time qPCR method for detection and enumeration of Mycobacterium spp. in surface water. doi:10.1128/AEM.00942-10 Appl Environ Microbiol 2010
Comparison of culture methods for isolation of nontuberculous mycobacteria from surface waters. doi:10.1128/AEM.02659-09 Appl Environ Microbiol 2010
The Use of Research Evidence in Two International Organizations' Recommendations about Health Systems. Healthc Policy 2009
Knowledge, attitudes and beliefs about tuberculosis in urban Morocco. East Mediterr Health J 2008
Co-infection with human immunodeficiency virus and tuberculosis in Asia. doi:10.1016/j.tube.2007.05.008 Tuberculosis (Edinb) 2007
The structure and computational analysis of Mycobacterium tuberculosis protein CitE suggest a novel enzymatic function. doi:10.1016/j.jmb.2006.09.086 names it J Mol Biol 2007
Latent tuberculosis: models, mechanisms, and novel prospects for eradication. doi:10.1053/spid.2002.127198 Semin Pediatr Infect Dis 2002
Soil-based organisms improve immune function: shift cytokine profile from TH2 to TH1. Posit Health News 1998
Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. doi:10.1164/ajrccm.154.4.8887603 Am J Respir Crit Care Med 1996
Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Bull Pan Am Health Organ 1996
Bacillus Calmette-Guérin complications in children born to HIV-1-infected women with a review of the literature. Pediatrics 1995
International controversies in interpreting the mantoux test with special reference to saudi arabia. J Family Community Med 1995
[The diagnosis of occupational tuberculosis of hospital personnel using the 2-stage intradermal Mantoux reaction]. Union Med Can 1989
Pericardial tuberculoma. An unusual cause of mediastinal mass. doi:10.1148/radiology.138.2.7455108 Radiology 1981
Accidental hypothermia treated without mortality. Surg Gynecol Obstet 1980
[The population of a large city in relation to radiodetection]. Rev Tuberc Pneumol (Paris) 1967
[Post-cure and sanatorial city]. Ann Med Leg Criminol Police Sci Toxicol 1948

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourRv2499c (Rv2499c, - strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): BkaR (bkaR).

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index 0.74 (95% CI -1.77 to 4.03). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.287 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=10 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInterconversion of acetate and oxaloacetate from citrate [catalytic activity: citrate = acetate + oxaloacetate].
Mycobrowser EC 4.1.-.- · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2526c · 100.0% identity
M. marinum MMAR_3845 · 85.9% identity
M. smegmatis MSMEG_4713 · 62.5% identity
M. orygis RJtmp_002583 · 100.0% identity
M. abscessus MAB_4378c · 61.9% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WPE1 SwissProt · reviewed · Evidence at protein level
UniProt nameCitrate lyase subunit beta-like protein
EC (curated) EC 4.1.-.-
Curated functionMay play a role in fatty acid biosynthesis.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category G Carbohydrate transport and metabolism
Preferred namecitE
eggNOG descriptionBelongs to the HpcH HpaI aldolase family
Orthologous groupCOG2301
EC number EC 4.1.3.34
KEGG orthology K01644
KEGG pathways map02020
Gene Ontology (17) GO:0000287, GO:0003674, GO:0005488, GO:0006082, GO:0006107, GO:0008150, GO:0008152, GO:0009987, GO:0019752, GO:0043167, GO:0043169, GO:0043436 +5 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.238 · purifying
Polymorphic sites (≥ 0.1% of strains) 6 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 52/53 (98%) · mean identity 78.7% · 4/4 closest MTBAP relatives
conserved across the genus (present in 52/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 10/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 51.1%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 9 in the ORF — 0 in the essential state, 0 growth-defect, 9 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 60.6666666667. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 9 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
CaveatRead with some caution: only 9 TA (Himar1) sites in the whole ORF (atlas median 13). The DeJesus 2017 call rests on fewer independent observations than for a longer gene. If this gene overlaps a neighbour (see Genomic-neighbour overlap section below), some of these 9 sites may fall inside the neighbour's ORF rather than its own, leaving even fewer truly informative sites than the raw count suggests. (P20.3)

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness in mouse infection, day 45 (in vivo) -4.770.03 required
fitness in mouse infection (in vivo) -2.690.018 required

Conditional fitness of transposon-disruption mutants across 2 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance340.0 ppm · rank 591/3519 (83.2th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length273 aa
Molecular weight28.9 kDa
Theoretical pI5.27
GRAVY0.01 (hydrophobic)
Aliphatic index93.5
Aromaticity0.044
Instability index40.8 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
HpcH_HpaIPF03328.21 9.7e-2811–211 HpcH/HpaI aldolase/citrate lyase
C-C_Bond_LyasePF15617.13 8.1e-07187–267 C-C_Bond_Lyase of the TIM-Barrel fold

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 6chu (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 9 solved

PDBMethodResolutionCoverage
6chu X-ray diffraction 1.61 Å 100%
1u5h X-ray diffraction 1.65 Å 100%
6arb X-ray diffraction 1.717 Å 100%
6cj3 X-ray diffraction 1.73 Å 100%
6cj4 X-ray diffraction 1.73 Å 100%
6aq4 X-ray diffraction 1.825 Å 100%
1u5v X-ray diffraction 1.85 Å 100%
6as5 X-ray diffraction 2.035 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (9 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 95.9

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
6as5-assembly1_B 1.00 0.97 0.95 0.97 100% 97% / 100% 7.5e-50 sig 6as5-assembly1_B CRYSTAL STRUCTURE OF PROTEIN CitE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MAGNESIUM, ACETOACETATE AND COENZYME A
6cj4-assembly1_A 1.00 0.99 0.86 0.99 90% 97% / 100% 3.1e-42 sig 6cj4-assembly1_A CRYSTAL STRUCTURE OF PROTEIN CITE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MAGNESIUM AND ACETOACETATE
6cj3-assembly1_A 1.00 0.99 0.87 0.99 90% 97% / 100% 3.3e-42 sig 6cj3-assembly1_A CRYSTAL STRUCTURE OF PROTEIN CITE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH MAGNESIUM AND PYRUVATE
1z6k-assembly1_A 1.00 1.00 0.81 1.00 100% 82% / 100% 7.4e-41 sig 1z6k-assembly1_A Citrate lyase beta subunit complexed with oxaloacetate and magnesium from M. tuberculosis
1u5h-assembly1_A 1.00 1.00 0.81 1.00 98% 82% / 100% 9.4e-41 sig 1u5h-assembly1_A Structure of Citrate Lyase beta subunit from Mycobacterium tuberculosis

Foldseek search of the AlphaFold DB model (mean pLDDT 95.9, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 7

Upstream (5' on genome)bkdA (- strand, 258 bp gap)
Downstream (3' on genome)Rv2499c (- strand, -4 bp gap)
Predicted operon citE · Rv2499c · fadE19 · accA1 · accD1 · scoB · scoA

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 7: citE · Rv2499c · fadE19 · accA1 · accD1 · scoB · scoA — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2573) exponential phase: operon of 10, Rv2495c · Rv2496c · Rv2497c · Rv2498c · Rv2499c · Rv2500c · Rv2501c · Rv2502c · Rv2503c · Rv2504c (coverage 16.76)
stationary phase: operon of 7, Rv2498c · Rv2499c · Rv2500c · Rv2501c · Rv2502c · Rv2503c · Rv2504c (coverage 17.11) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (3 TF) Rv0023 (represses) · Rv1816 (activates) · Rv2506 (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: Rv2499c (oxidase regulatory-like protein), high confidence (score 993, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 31 partners at medium confidence (14 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 31 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv2499c oxidase regulatory-like protein 998 993 ctx neighborhood:882 cooccurence:760 coexpression:761 textmining:816
Rv2501c accA1 acetyl/propionyl-CoA carboxylase subuit alpha 990 981 ctx neighborhood:881 coexpression:826 textmining:528
Rv2500c fadE19 acyl-CoA dehydrogenase FadE19 995 977 ctx neighborhood:881 coexpression:787 textmining:830
Rv3075c curated paralog hypothetical protein 949 926 database:900
Rv2502c accD1 acetyl-/propionyl-CoA carboxylase subunit beta 991 907 ctx neighborhood:881 textmining:916
Rv2503c scoB succinyl-CoA:3-ketoacid-CoA transferase subunit B 945 886 ctx neighborhood:881 textmining:540
Rv2504c scoA succinyl-CoA:3-ketoacid-CoA transferase subunit A 987 885 ctx neighborhood:881 textmining:899
Rv2506 TetR family transcriptional regulator 918 776 ctx neighborhood:714 textmining:651
Rv2495c bkdC branched-chain keto acid dehydrogenase E2 component 887 770 ctx neighborhood:723 textmining:533
Rv2497c bkdA 3-methyl-2-oxobutanoate dehydrogenase subunit alpha 840 740 ctx neighborhood:724 textmining:411
Rv2496c bkdB 3-methyl-2-oxobutanoate dehydrogenase subunit beta 746 737 ctx neighborhood:723
Rv0727c fucA L-fuculose phosphate aldolase FucA 731 732 coexpression:732
Rv2505c fadD35 fatty-acid--CoA ligase FadD35 850 568 ctx neighborhood:567 textmining:667
Rv1130 prpD 2-methylcitrate dehydratase 543 524
Rv0216 hydratase 524 501 ctx fusion:401

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: citrate (pro-3S)-lyase subunit beta
  • MTBC0 PGAP product: citrate (pro-3S)-lyase subunit beta
  • Pfam (hmmscan --cut_ga): HpcH_HpaI PF03328.21 (E=1e-27), C-C_Bond_Lyase PF15617.13 (E=8e-07)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217014.1)
  • Domains: Pfam-A via hmmscan --cut_ga — HpcH_HpaI (PF03328.21), C-C_Bond_Lyase (PF15617.13)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG2301
  • Curated reference: UniProt P9WPE1 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 95.9)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 31 functional partner(s); context anchor Rv2499c
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_002660|Rv2498c|citE
MNLRAAGPGWLFCPADRPERFAKAAAAADVVILDLEDGVAEAQKPAARNALRDTPLDPERTVVRINAGGTADQARDLEALAGTAYTTVMLPKAESAAQVIELAPRDVIALVETARGAVCAAEIAAADPTVGMMWGAEDLIATLGGSSSRRADGAYRDVARHVRSTILLAASAFGRLALDAVHLDILDVEGLQEEARDAAAVGFDVTVCIHPSQIPVVRKAYRPSHEKLAWARRVLAASRSERGAFAFEGQMVDSPVLTHAETMLRRAGEATSE